Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study supports long-term VNS (vagus nerve stimulation) for epilepsy:

This article was originally published in Clinica

Executive Summary

Cyberonics claims that the largest prospective long-term study of vagus nerve stimulation shows that the procedure is an effective long-term treatment for patients with refractory epilepsy and that its effectiveness increases over time. The median reduction in seizure frequency was 34% and 45% at a three- and 12-month follow-up respectively, revealed the 195-patient, 15-month, multicentre study, published in Epilepsia (September). Results also showed that 20% of patients sustained greater than 75% reduction in seizure occurrence at 12 months, said the Houston, Texas company. Cyberonics' NCP nerve stimulator was approved for treating epilepsy in the US in 1997.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074900

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel